MedPath

Magnesium Sulphate as Adjuvant in Acute Organophosphorus Poisoning

Phase 3
Conditions
Health Condition 1: T600- Toxic effect of organophosphate and carbamate insecticides
Registration Number
CTRI/2024/02/063307
Lead Sponsor
JLN Medical College and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients arriving in the emergency OPD with history of OPC consumption and clinical features of cholinergic toxidrome of typical organophosphorus compound poisoning.

Exclusion Criteria

Doubtful history

Poisoning with unknown compound

Treatment initiated before admission

Patient refusal to consent

Patient sensitive /allergic to any of the study drugs.

Cardiovascular disease patients(1-and2-degree heartblock)

Severe hepatic and renal disease.

History of epilepsy or bleeding tendencies

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath